110 related articles for article (PubMed ID: 35036831)
1. Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial).
Gallagher B; Foley M; Slattery CM; Gusciute G; Shanahan E; McLoughlin DM
HRB Open Res; 2020; 3():90. PubMed ID: 35036831
[No Abstract] [Full Text] [Related]
2. Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]).
Jelovac A; McCaffrey C; Terao M; Shanahan E; Mohamed E; Whooley E; McDonagh K; McDonogh S; Igoe A; Loughran O; Shackleton E; O'Neill C; McLoughlin DM
BMC Psychiatry; 2023 Nov; 23(1):850. PubMed ID: 37974160
[TBL] [Abstract][Full Text] [Related]
3. Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).
Finnegan M; Ryan K; Shanahan E; Harkin A; Daly L; McLoughlin DM
Pilot Feasibility Stud; 2016; 2():38. PubMed ID: 27965856
[TBL] [Abstract][Full Text] [Related]
4. Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial.
Finnegan M; Galligan T; Ryan K; Shanahan E; Harkin A; Daly L; McLoughlin DM
J ECT; 2019 Jun; 35(2):115-121. PubMed ID: 30531397
[TBL] [Abstract][Full Text] [Related]
5. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P
Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101
[TBL] [Abstract][Full Text] [Related]
6. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
7. The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial.
Knyahnytska Y; Zomorrodi R; Kaster T; Voineskos D; Trevizol A; Blumberger D
JMIR Res Protoc; 2022 Jan; 11(1):e30163. PubMed ID: 34882570
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Green CE; Perez AM; Iqbal S; Pillemer S; Foulkes A; Shah A; Charney DS; Mathew SJ
Am J Psychiatry; 2013 Oct; 170(10):1134-42. PubMed ID: 23982301
[TBL] [Abstract][Full Text] [Related]
9. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
[TBL] [Abstract][Full Text] [Related]
11. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
[TBL] [Abstract][Full Text] [Related]
12. Protocol Development for a Qualitative Methodological Study Within a Trial (Qual-SWAT): The KARMA-Dep-2 Trial.
McCaffrey J; Hunter A
HRB Open Res; 2023; 6():29. PubMed ID: 37361338
[TBL] [Abstract][Full Text] [Related]
13. Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial.
Knyahnytska Y; Zomorrodi R; Kaster T; Voineskos D; Trevizol A; Blumberger D
JMIR Res Protoc; 2023 Jan; 12():e41013. PubMed ID: 36573651
[TBL] [Abstract][Full Text] [Related]
14. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
[TBL] [Abstract][Full Text] [Related]
15. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
16. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
